A population-based case-control study of non-Hodgkin's lymphoma (NHL) that included nearly 1600 patients with NHL and more than 2500 control participants was conducted by the Principal Investigator and colleagues in the San Francisco Bay Area between 1988 and 1995. NHL cases were obtained using rapid case ascertainment by the Northern California Cancer Center and control participants were identified using random digit dial and the Healthcare Financing Administration files. Pathology materials for the NHL patients included in the study were reviewed and classified of this study are: 1) to evaluate the association between exposure data collected in this large study and subtypes of NHL defined using the Working Formulation with emphasis on the investigation of risk factors found to be of importance in the main analyses of all NHL; and 2) to complete detailed analyses to investigate the association between risk for NHL and occupational and chemical exposures including Agent Orange, reproductive and hormonal exposures among women , support for hypotheses that indicated there are etiologic differences across NHL subtypes that can be characterized by a unique set of associated risk factors. Differentiation of risk factors by NHL subtypes will provide important clues to detailed analyses between exposures of interest and risk for NHL with adjustment for potential confounders and effect modifiers. These data may explain inconsistencies in results from earlier NHL studies constrained by limited sample size and exposure data. They also may provide important additional information about the role of exposures that alter Th1 or Th2 pathways and the process of lymphomagenesis. These data will be used as preliminary results for a larger Bay Area study of lymphoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA089745-02
Application #
6489434
Study Section
Subcommittee G - Education (NCI)
Program Officer
Verma, Mukesh
Project Start
2001-01-03
Project End
2003-12-31
Budget Start
2002-01-01
Budget End
2003-12-31
Support Year
2
Fiscal Year
2002
Total Cost
$73,750
Indirect Cost
Name
University of California San Francisco
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Law, Philip J; Berndt, Sonja I; Speedy, Helen E et al. (2017) Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun 8:14175
Wang, Sophia S; Vajdic, Claire M; Linet, Martha S et al. (2015) Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol 181:406-21
Kane, Eleanor; Skibola, Christine F; Bracci, Paige M et al. (2015) Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium. Cancer Epidemiol Biomarkers Prev 24:1061-70
Foo, Jia Nee; Smedby, Karin E; Akers, Nicholas K et al. (2013) Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk. Am J Hum Genet 93:167-72
Kane, E V; Bernstein, L; Bracci, P M et al. (2013) Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies. Ann Oncol 24:433-41
Navon, Oron; Sul, Jae Hoon; Han, Buhm et al. (2013) Rare variant association testing under low-coverage sequencing. Genetics 194:769-79
Conde, Lucia; Foo, Jia-Nee; Riby, Jacques et al. (2013) X chromosome-wide association study of follicular lymphoma. Br J Haematol 162:858-62
Skibola, C F; Akers, N K; Conde, L et al. (2012) Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma. Tissue Antigens 79:279-86
Nieters, Alexandra; Conde, Lucia; Slager, Susan L et al. (2012) PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood 120:4645-8
Slager, Susan L; Skibola, Christine F; Di Bernardo, Maria Chiara et al. (2012) Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 120:843-6

Showing the most recent 10 out of 52 publications